Investigation of coco-glucoside as a novel intestinal permeation enhancer in rat models

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 88, Issue 3, 2014, Pages 856-865

  Aguirre, Tanira A S ^a,b   Rosa, Mónica ^b   Guterres, Sílvia S ^c   Pohlmann, Adriana R ^c   Coulter, Ivan ^b   Brayden, David J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b DUBLIN CITY UNIVERSITY   (Ireland)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Alkyl polyglycosides; Coco glucoside; Oral bioavailability; Oral peptide delivery; Permeation enhancers; Salmon calcitonin

Indexed keywords

COCO GLUCOSIDE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLUCOSIDE; PENETRATION ENHANCING AGENT; SALCATONIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CACO 2 CELL LINE; CONTENT ANALYSIS; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; GASTROINTESTINAL ABSORPTION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM; LONG TERM EXPOSURE; MALE; MUCUS SECRETION; NONHUMAN; PERMEABILITY; RAT; TISSUE INJURY; ANIMAL; ANIMAL MODEL; COCONUT; DRUG EFFECTS; HEPG2 CELL LINE; HUMAN; INTESTINE ABSORPTION; INTESTINE MUCOSA; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CACO-2 CELLS; COCOS; GLUCOSIDES; HEP G2 CELLS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MALE; MODELS, ANIMAL; PERMEABILITY; RATS; RATS, WISTAR;

EID: 84912073467     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2014.10.013     Document Type: Article

References (48)

1. D. Siccardi, J.R. Turner, and R.J. Mrsny Regulation of intestinal epithelial function: a link between opportunities for macromolecular drug delivery and inflammatory bowel disease Adv. Drug Deliv. Rev. 57 2005 219 235
2. J.F. Woodley Enzymatic barriers for GI peptide and protein delivery Crit. Rev. Ther. Drug Carrier Syst. 11 1994 61 95
3. Y.H. Lee, and P.J. Sinko Oral delivery of salmon calcitonin Adv. Drug Deliv. Rev. 42 2000 225 238
4. S. Maher, T.W. Leonard, J. Jacobsen, and D.J. Brayden Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic Adv. Drug Deliv. Rev. 61 2009 1427 1449
5. B.J. Aungst Absorption enhancers: applications and advances AAPS J. 14 2012 10 18
6. S. Maher, and D.J. Brayden Overcoming poor permeability: translating permeation enhancers for oral peptide delivery Drug Discov. Today Technol. 9 2012 e113 e119 10.1016/j.ddtec.2011.11.006
7. S. Tuvia, D. Pelled, K. Marom, P. Salama, M. Levin-Arama, and I. Karmeli A novel suspension formulation enhances intestinal absorption of macromolecules via transient and reversible transport mechanisms Pharm. Res. 31 2014 2010 2021
8. B.J. Aungst Intestinal permeation enhancers J. Pharm. Sci. 89 2000 429 442
9. H. Uchida, M. Kondoh, T. Hanada, A. Takahashi, T. Hamakubo, and K. Yagi A claudin-4 modulator enhances the mucosal absorption of a biologically active peptide Biochem. Pharmacol. 79 2010 1437 1444
10. Laura M. Tarantino, Agency Response Letter GRAS Notice No. GRN 000237 CFSAN/Office of Food Additive Safety, 2008. < http://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm153914.htm > (accessed 16.10.14).
11. K. Petechin, C. Boyke, Cleaning Composition with Decyl and Coco Glucosides, US Patent 2013/0115205 A1, 2013.
12. A. Kovacevic, R.H. Müller, S. Savic, G. Vuleta, C.M. Keck, Preparation and characterization of alkylpolyglucoside - based solid lipid nanoparticles, in: Transactions of the 36th Annual Meeting and Exposition of the Controlled Release Society, 2011. < http://www.controlledreleasesociety.org/meetings/Archives/2011AnnualMeeting/Abstracts/100580.pdf > (accessed 17.10.14).
13. BASF, Produc Datasheet - Plantacare 818 UP, Rev. 7.0, n.d., p. 2. < http://e-applications.basf-ag.de/data/basf-pcan/pds2/pds2-web.nsf/D2A40CF69E17C275C12576570041971E/$File/PLANTACARE-r--818-UP-E.pdf > (accessed 03.10.14).
14. Cognis, PLANTACARE® 818 UP, 2004, p. 2. < http://www.bsibusiness.com/uploads/product/pdf/292-pdf.pdf > (accessed 06.10.14).
15. COGNIS, Product Data Sheet PLANTACARE® 818 UP, n.d., p. 2. < http://www.cospha.ro/dbimg/Plantacare 818 UP.pdf > (accessed 03.10.14).
16. F. Ahsan, J. Arnold, E. Meezan, and D.J. Pillion Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats Pharm. Res. 18 2001 1742 1746
17. D.J. Pillion, P. Wang, J. Yorks, P. McCann, and E. Meezan Systemic absorption of insulin and glucagon applied topically to the eyes of rats and a diabetic dog J. Ocul. Pharmacol. Ther. 11 1995 283 295
18. D.J. Pillion, F. Ahsan, J.J. Arnold, B.M. Balusubramanian, O. Piraner, and E. Meezan Synthetic long-chain alkyl maltosides and alkyl sucrose esters as enhancers of nasal insulin absorption J. Pharm. Sci. 91 2002 1456 1562
19. F. Ahsan, J.J. Arnold, T. Yang, E. Meezan, E.M. Schwiebert, and D.J. Pillion Effects of the permeability enhancers, tetradecylmaltoside and dimethyl-beta-cyclodextrin, on insulin movement across human bronchial epithelial cells (16HBE14o-) Eur. J. Pharm. Sci. 20 2003 27 34
20. L. Illum Nasal drug delivery - recent developments and future prospects J. Control. Release 161 2012 254 263 10.1016/j.jconrel.2012.01.024
21. E.T. Maggio, E. Meezan, D. Ghambeer, and D.J. Pillion Highly bioavailable nasal calcitonin - potential for expanded use in analgesia Drug Deliv. Technol. 10 2010 58 63
22. T. Yang, J.J. Arnold, and F. Ahsan Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin J. Drug Target. 13 2005 29 38
23. S.B. Petersen, L.G. Nielsen, U.L. Rahbek, M. Guldbrandt, and D.J. Brayden Colonic absorption of salmon calcitonin using tetradecyl maltoside (TDM) as a permeation enhancer Eur. J. Pharm. Sci. 48 2013 726 734
24. S.B. Petersen, G. Nolan, S. Maher, U.L. Rahbek, M. Guldbrandt, and D.J. Brayden Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers Eur. J. Pharm. Sci. 47 2012 701 712
25. P.J. O'Brien, W. Irwin, D. Diaz, E. Howard-Cofield, C.M. Krejsa, and M.R. Slaughter High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening Arch. Toxicol. 80 2006 580 604
26. N.R. Pallas, and B.A. Pethica The surface tension of water Colloids Surf. 6 1983 221 227
27. I.M. Umlong, and K. Ismail Micellization behaviour of sodium dodecyl sulfate in different electrolyte media Colloids Surf., A: Physicochem. Eng. Asp. 299 2007 8 14
28. A.W. Cuthbert, and H.S. Margolius Kinins stimulate net chloride secretion by the rat colon Br. J. Pharmacol. 75 1982 587 598
29. A.L. Ungell, S. Nylander, S. Bergstrand, a. Sjöberg, and H. Lennernäs Membrane transport of drugs in different regions of the intestinal tract of the rat J. Pharm. Sci. 87 1998 360 366
30. S. Maher, R. Kennelly, V.A. Bzik, A.W. Baird, X. Wang, and D. Winter Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae Eur. J. Pharm. Sci. 38 2009 291 300
31. E.G. Walsh, S. Maher, M. Devocelle, P.J. O'Brien, A.W. Baird, and D.J. Brayden High content analysis to determine cytotoxicity of the antimicrobial peptide, melittin and selected structural analogs Peptides 32 2011 1764 1773
32. D.J. Brayden, and E. Walsh Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative AAPS J. 16 2014 1064 1076
33. W.-P. Cheng, C. Thompson, S.M. Ryan, T. Aguirre, L. Tetley, and D.J. Brayden In vitro and in vivo characterisation of a novel peptide delivery system: amphiphilic polyelectrolyte-salmon calcitonin nanocomplexes J. Control. Release 147 2010 289 297
34. L.M. Feighery, S.W. Cochrane, T. Quinn, A.W. Baird, D. O'Toole, and S.-E. Owens Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro Pharm. Res. 25 2008 1377 1386
35. E.T. Maggio, and P. Grasso Oral delivery of octreotide acetate in Intravail® improves uptake, half-life, and bioavailability over subcutaneous administration in male Swiss webster mice Regul. Pept. 167 2011 233 238
36. G. Hetsroni, M. Gurevich, a. Mosyak, R. Rozenblit, and Z. Segal Boiling enhancement with environmentally acceptable surfactants Int. J. Heat Fluid Flow 25 2004 841 848
37. G. Zhang, and T.A. Neubert Use of detergents to increase selectivity of immunoprecipitation of tyrosine phosphorylated peptides prior to identification by MALDI quadrupole-TOF MS Proteomics 6 2006 571 578
38. K. Holmberg, B. Jonsson, B. Kronberg, and B. Lindman Surfactants and Polymers in Aqueous Solution second ed. 2002 John Wiley & Sons Ltd.
39. A. Maroni, L. Zema, M.D. Del Curto, A. Foppoli, and A. Gazzaniga Oral colon delivery of insulin with the aid of functional adjuvants Adv. Drug Deliv. Rev. 64 2012 540 556
40. A. Rubinstein, B. Tirosh, M. Baluom, T. Nassar, A. David, and R. Radai The rationale for peptide drug delivery to the colon and the potential of polymeric carriers as effective tools J. Control. Release 46 1997 59 73
41. S.A. Gibson, C. McFarlan, S. Hay, and G.T. MacFarlane Significance of microflora in proteolysis in the colon Appl. Environ. Microbiol. 55 1989 679 683
42. B.J. Aungst, H. Saitoh, D.L. Burcham, S. Huang, S.A. Mousa, and M.A. Hussain Enhancement of the intestinal absorption of peptides and nonpeptides J. Control. Release 41 1996 19 31
43. N.M. Mentha Oral delivery and recombinant production of peptide hormones. Part I: Making oral delivery possible Biopharm. Int. 17 2004 38 43
44. R.L. Oberle, T.J. Moore, and D.a. Krummel Evaluation of mucosal damage of surfactants in rat jejunum and colon J. Pharmacol. Toxicol. Methods 33 1995 75 81
45. G. Fetih, S. Lindberg, K. Itoh, N. Okada, T. Fujita, and F. Habib Improvement of absorption enhancing effects of n-dodecyl-beta-d-maltopyranoside by its colon-specific delivery using chitosan capsules Int. J. Pharm. 293 2005 127 135
46. S. Mansoor, Y.S. Youn, and K.C. Lee Oral delivery of mono-PEGylated sCT (Lys18) in rats: regional difference in stability and hypocalcemic effect Pharm. Dev. Technol. 10 2005 389 396
47. L.-A.B. Rawlinson, P.J. O'Brien, and D.J. Brayden High content analysis of cytotoxic effects of pDMAEMA on human intestinal epithelial and monocyte cultures J. Control. Release 146 2010 84 92
48. A.R.D. Stebbing Interpreting "dose-response" curves using homeodynamic data: with an improved explanation for hormesis Dose Response 7 2009 221 233